About our Editors

Britta Engelhardt, Editorial Board Member
University of Bern, Switzerland
Find publications in PubMed

1982 – 1987: Human Biology (Immunology), at the Philipps-University, Marburg, Germany. Diploma Thesis: 1986 – 1987 "Immunotherapy of experimental autoimmune encephalomyelitis: monoclonal antibodies directed against the Interleukin-2 receptor and Cyclosporin A" at the Max-Planck-Institute, Clinical Research Group for Multiple Sclerosis, Würzburg, Germany, laboratory of Professor Dr. Hartmut Wekerle.
Diplom-Humanbiologe: University diploma for Human Biology, final grade: "excellent".
1988 – 1990: PhD Thesis: "Immune-specific interaction of rat brain capillary endothelium with syngeneic antigen-specific T cells" Max-Planck-Institute, Clinical Research Group for Multiple Sclerosis, Würzburg, Germany and Max-Planck Institute for Psychiatry, Martinsried, Germany in the laboratory of Professor Dr. H. Wekerle, final grade: "magna cum laude".
1991: PhD in Human Biology (Dr.rer.physiol.)
1991 – 1993: Post-doctoral Fellow: "Investigation of adhesion molecules involved in lymphocyte recruitment across the blood-brain barrier" at Stanford University, California, USA, Department of Pathology in the laboratory of Professor Dr. Eugene C. Butcher
June 1993 – October 1993; Research Group Leader: Institute for Brain Research, Section Immunopathology of the Nervous System at the Eberhard-Karls-University in Tübingen, Germany with Professor Dr. Dr. H. J. Schlüsener.
November 1993 – June 1999: Max-Planck Institute for Physiological and Clinical Research, W.G. Kerckhoff-Institute, Department of Molecular Cell Biology, Bad Nauheim, Germany; Director: Professor Dr. Werner Risau.
July 1999 – July 2001: Max-Planck Institute for Physiological and Clinical Research, W.G. Kerckhoff-Institute, Department of Vascular Cell Biology, Bad Nauheim, Germany, Director: Professor Dr. Dietmar Vestweber.
August 2001 – October 2003: Max-Planck-Institute for Vascular Cell Biology, Münster, Germany, Director: Professor Dr. Dietmar Vestweber.
November 2003-: Director/Chair, University of Bern, Theodor-Kocher Institute, Switzerland.
1998: "Habilitation" (Postdoctoral lecture qualification): Venia Legendi for Immunology and Cell Biology, Medical Faculty of the Philipps University Marburg, Germany.
November 1999: C3-groupleader position at the Max-Planck Institute for Physiological and Clinical Research, W.G. Kerckhoff-Institute, Bad Nauheim, Germany.
November 2003: Full Professor (Ordinaria) for Immunobiology and Director of the Theodor-Kocher Institute, University of Bern, Switzerland.
Research Focus: Leukocyte trafficking into the central nervous system; blood-brain barrier research.